1. Home
  2. Analysis

Macrocytosis and drugs of ingredients of meloxicam (a real world drug study)


Summary:

Macrocytosis is found among people who take drugs with ingredients of meloxicam, especially for people who are female, 50-59 old . This phase IV clinical study is created by eHealthMe based on reports of 88,810 people who have side effects when taking drugs with ingredients of meloxicam from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Anjeso, Meloxicam, Mobic, Qmiiz odt, Vivlodex.

On Jul, 05, 2026

88,810 people reported to have side effects when taking drugs with ingredients of meloxicam.
Among them, 13 people (0.01%) have Macrocytosis

What is Macrocytosis?

Macrocytosis (enlargement of red blood cells with near-constant haemoglobin concentration) is found to be associated with 307 drugs and 583 conditions by eHealthMe. Check the latest studies of Macrocytosis.

Number of reports submitted per year:

Could drugs with ingredients of meloxicam cause Macrocytosis?

Gender of people who have Macrocytosis when taking drugs with ingredients of meloxicam *:

  • female: 92.31 %
  • male: 7.69 %

Age of people who have Macrocytosis when taking drugs with ingredients of meloxicam *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 9.09 %
  • 50-59: 72.73 %
  • 60+: 18.18 %

Conditions people have *:

You may use this to check any potential undetected conditions.

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 6 people, 46.15%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 30.77%
  3. Renal Impairment (severely reduced kidney function): 1 person, 7.69%
  4. Anaemia (lack of blood): 1 person, 7.69%

Other drugs people take *:

You may use this to check any potential interacting drugs.

  1. Aubagio: 5 people, 38.46%
  2. Cambia: 4 people, 30.77%
  3. Enbrel: 4 people, 30.77%
  4. Premarin: 4 people, 30.77%
  5. Ventolin: 4 people, 30.77%
  6. Breo Ellipta: 4 people, 30.77%
  7. Zoloft: 3 people, 23.08%
  8. Humira: 3 people, 23.08%
  9. Neurontin: 3 people, 23.08%
  10. Nexium: 3 people, 23.08%

Other side effects people have besides Macrocytosis *:

You may use this to check any potential undetected side effects.

  1. White Blood Cell Count Decreased: 5 people, 38.46%
  2. Fatigue (feeling of tiredness): 5 people, 38.46%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 30.77%
  4. Hair Texture Abnormal: 4 people, 30.77%
  5. Mean Cell Volume Increased (more than normal average red blood cell volume): 4 people, 30.77%
  6. Hair Loss: 4 people, 30.77%
  7. Pain In Extremity: 4 people, 30.77%
  8. Diarrhea: 4 people, 30.77%
  9. Influenza Like Illness: 4 people, 30.77%
  10. Weakness: 4 people, 30.77%

* Approximation only. Some reports may have incomplete information.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related publications that referenced our studies

Related studies

Drugs with ingredients of meloxicam, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on meloxicam. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.